Our Team
Our team is dedicated to improving outcomes and decreasing the cost of healthcare for spine surgery and beyond.
Leadership Team
Mike is a seasoned MedTech operator, entrepreneur, and cofounder of Carlsmed. He was named as an EY Entrepreneur of the Year and to the SD500 as one of the most influential people in San Diego. Mike has operating experience at private and public companies, including NuVasive Specialized Orthopedics, Zimmer Biomet, Orchid Orthopedics, X-Spine Systems, and YSI. He is active in the entrepreneur community and servers as an advisor to San Diego based non-profits EvoNexus and SD Connect. Mike has a B.S. in Mechanical Engineering from the University of Dayton.
Jodi supports leadership in the development of long-term business planning and execution of shorter-term objectives. She helps to develop internal and external messaging to effectively communicate and implement Carlsmed’s vision. Jodi holds an M.B.A. from California State University and B.A. in Political Science from the University of Illinois.
Mark leads Carlsmed’s direct and indirect sales teams. He has broad experience in bringing disruptive technologies into the operating room with two decades of sales leadership in roles at market leaders NuVasive, U.S. Surgical, and ConMed, and start-up Lanx. Mark has a B.A. in Education from the University of Alberta.
Sharon leads clinical and marketing. She has held senior leadership positions in marketing and surgical affairs at market leaders J&J and Stryker, as well as key C-suite positions at startups Micropore Biosurgery, N-Spine, and Tissue Regeneration Systems, which all had successful exits. Sharon has a B.S. in Medical Technology from Loyola University Maryland.
Alex is a MedTech finance executive and former equity analyst. He led equity research for Lazard Capital Markets and Wedbush Morgan, and held operating roles at private and public companies, including Biolase, Circuit Therapeutics, and Arstasis. Alex currently serves as a Board Member at Zelegent, Paragonix Technologies, and 8i Acquisition Corp and previously served on the boards of Medcura, Neumedicines, and Biolase. Alex has an M.D. from Harvard Medical School, a B.A. in Biophysics from Cornell University, and is a CFA charter holder.
Niall leads IP and technology strategy and is cofounder of Carlsmed. He is a spine industry veteran, with previous technology leadership roles at Alphatec Spine, Ellipse Technologies, NuVasive, and J&J DePuy Synthes Spine. Niall earned a J.D. from Suffolk University and an M.S. and B.S. degree in Biomedical Engineering from Case Western Reserve University.
Shariq directs digital surgery for Carlsmed. He has a strong track record of entrepreneurship and execution in technology and executive leadership roles at MedTech companies Intelliguard Solutions and Safety Syringes. Shariq has an M.B.A. in Technology Management from National University, a B.S. in Computer Science and Engineering from UCSD, and a B.S. in Information Technology from National University.
Daryle is an experienced supply chain leader and operations professional with experience working in the medical device industry, including more than twenty years at Zimmer Biomet. Daryle has a B.A. in Psychology from the University of California at San Diego.
Karen’s deep industry experience includes leadership roles at NuVasive, Medtronic, Alaris, and Mallinckrodt. She has a B.S. in Materials Engineering from Rensselaer Polytechnic Institute and holds certificates as a CQM/OE in quality and a RAC in regulatory affairs.
Board of Directors
Jon is a General Partner at U.S. Venture Partners. He serves as a Board Member at Edgewise Therapeutics, Inari Medical, Silverback Therapeutics, Cleave Therapeutics, HealthJoy, Okami Medical, Omada Health, Nuvaira, Ribon Therapeutics, Route 92 Medical and Sparrow Pharmaceuticals. Jon previously served as a Board Member at eFFECTOR Therapeutics, Lutonix, Microvention, OncoMed Pharmaceuticals, Sequent Medical and Proteolix. Before USVP, Jon was an Assistant Professor of Neurology and Director of the Neurology-Neurosurgery Special Care Unit at Cornell Medical Center. He holds an M.D. from the University of Florida College of Medicine, an M.B.A. from Columbia University, and an A.B. in Economics from Dartmouth College.
Robert is a General Partner and Head of Healthcare who leads venture and growth investments at B Capital in the sector. Robert and his team have led investments in Hotspot Therapeutics, Lively, Aetion, Oncomyx, and Triumvira OR. He currently serves as a Board Director or Board Observer at Hotspot Therapeutics, Lively, Aetion, Oncomyx, and Triumvira. Previously, he served as a Board Director or Observer at Impel NeuroPharma, Silk Road Medical, TigerConnect, Avalyn Pharma, Neocis, Telcare, VisitPay, IntersectENT, iRhythm, Omada, TalkSpace, and iCardiac. Prior to his career in venture capital, Robert led Marketing and Business Development at Hansen Medical. He earned an M.D. from Harvard University, an M.B.A. from Harvard Business School, an M.S. in Systems Engineering from the Massachusetts Institute of Technology, and an M.A. in International Relations from Kings College London.
Phil serves as Senior Advisor at US Venture Partners, following 20 years as a managing general partner of the firm. He previously served as a Board Member at Aerogen, Aptus Endosystems, CardioThoracic Systems, CardioVascular Imaging Systems, CoCensys, Compugen, Dotomi, FemRx, HeartFlow, La Jolla Pharmaceuticals, Penederm, 3Dfx Interactive, RelayHealth, SentreHEART, Simpirica Spine, Synarc, St. Francis Medical Technologies, The Immune Response Corporation, Vical, Xoma and Zoran. Prior to USVP, Phil was the President and CEO of Oximetrix, a manufacturer of critical care instruments and disposables. He also served on the Board of Trustees of Cornell University and was the Chair of eCornell for nearly 20 years. He earned an M.B.A. from Harvard Business School, an M.S. in Engineering Physics from George Washington University, and a B.M.E. from Cornell University.
Kevin is a Board Member at Intrinsic Therapeutics, Miach Orthopaedics, Razor Medical, FzioMed, Shoulder Innovations, and Moximed. He previously served on the Board at Rotation Medical, Ceterix, and Pivot Medical. Kevin is the past CEO of St. Francis Medical Technologies and Moximed, as well as past Worldwide President of Johnson & Johnson’s DePuy Orthopedics. He has a B.S. in Accounting from West Virginia University.
Niall leads IP and technology strategy and is cofounder of Carlsmed. He is a spine industry veteran, with previous technology leadership roles at Alphatec Spine, Ellipse Technologies, NuVasive, and J&J DePuy Synthes Spine. Niall earned a J.D. from Suffolk University and an M.S. and B.S. degree in Biomedical Engineering from Case Western Reserve University.
Mike is a seasoned MedTech operator, entrepreneur, and cofounder of Carlsmed. He was named as an EY Entrepreneur of the Year and to the SD500 as one of the most influential people in San Diego. Mike has operating experience at private and public companies, including NuVasive Specialized Orthopedics, Zimmer Biomet, Orchid Orthopedics, X-Spine Systems, and YSI. He is active in the entrepreneur community and servers as an advisor to San Diego based non-profits EvoNexus and SD Connect. Mike has a B.S. in Mechanical Engineering from the University of Dayton.
Management
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Dolores, facilis vitae similique nihil, pariatur, delectus voluptatum ea sapiente incidunt tenetur non officia adipisci repellendus neque libero error facere voluptatibus explicabo?